Free Trial
Benjamin Rossi

Benjamin Rossi Analyst Performance

Healthcare Services Equity Research at JPMorgan Chase & Co.

Benjamin Rossi is a stock analyst at JPMorgan Chase & Co. in the medical sector, covering 9 publicly traded companies. Over the past year, Benjamin Rossi has issued 16 stock ratings, including buy, hold, and sell recommendations. While full access to Benjamin Rossi's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Benjamin Rossi's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
16 Last 0 Years
Buy Recommendations
37.50% 6 Buy Ratings
Companies Covered
9 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy37.5%6 ratings
Hold50.0%8 ratings
Sell12.5%2 ratings

Out of 16 total stock ratings issued by Benjamin Rossi at JPMorgan Chase & Co., the majority (50.0%) have been Hold recommendations, followed by 37.5% Buy and 12.5% Sell.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NYSE
77.8% of companies on NYSE
7 companies
NASDAQ
22.2% of companies on NASDAQ
2 companies

Benjamin Rossi, an analyst at JPMorgan Chase & Co., currently covers 9 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
9 companies
100.0%

Benjamin Rossi of JPMorgan Chase & Co. specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
5 companies
55.6%
MED - HOSPITALS
3 companies
33.3%
MED - OUTP/HM CRE
1 company
11.1%

Benjamin Rossi's Ratings History at JPMorgan Chase & Co.

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
InnovAge Holding Corp. stock logo
INNV
InnovAge
2/23/2026Boost Price Target$9.00$7.00Underweight
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
2/20/2026Boost Price Target$528.45$535.00Neutral
Ardent Health, Inc. stock logo
ARDT
Ardent Health
1/20/2026Lower Price Target$8.58$11.00Neutral
PACS Group, Inc. stock logo
PACS
PACS Group
12/17/2025Initiated Coverage$34.23$44.00Overweight
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
11/24/2025Lower Price Target$71.87$100.00Overweight
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
11/24/2025Lower Price Target$16.68$20.00Neutral
Ardent Health, Inc. stock logo
ARDT
Ardent Health
11/24/2025Lower Price Target$8.99$12.00Neutral
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
11/13/2025Boost Price Target$196.47$230.00Overweight
U.S. Physical Therapy, Inc. stock logo
USPH
U.S. Physical Therapy
9/18/2025Initiated Coverage$78.78$110.00Overweight
Surgery Partners, Inc. stock logo
SGRY
Surgery Partners
9/18/2025Initiated Coverage$21.79$27.00Neutral
InnovAge Holding Corp. stock logo
INNV
InnovAge
9/18/2025Initiated Coverage$4.98$5.00Underweight
Concentra Group Holdings Parent, Inc. stock logo
CON
Concentra Group Holdings Parent
9/18/2025Initiated Coverage$20.81$31.00Overweight
Ardent Health, Inc. stock logo
ARDT
Ardent Health
8/11/2025Lower Price Target$11.87$15.00Neutral
HCA Healthcare, Inc. stock logo
HCA
HCA Healthcare
8/4/2025Boost Price Target$363.14$370.00Neutral
Universal Health Services, Inc. stock logo
UHS
Universal Health Services
8/4/2025Lower Price Target$165.98$195.00Neutral
Tenet Healthcare Corporation stock logo
THC
Tenet Healthcare
8/4/2025Boost Price Target$161.37$200.00Overweight